Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions.
Alexion Pharmaceuticals Inc. said that recent advances in the RNA-interference (RNAi) therapeutic space gave it the confidence to return...








